Life sciences VC Omega Funds closes $647m funding round
Life sciences venture capital (VC) company Omega Funds has closed its eighth fund, with capital commitments totalling $647m. As with…
Life sciences venture capital (VC) company Omega Funds has closed its eighth fund, with capital commitments totalling $647m. As with…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for EURneffy, an adrenaline (epinephrine) nasal spray for…
According to GlobalData analysis, currently marketed and pipeline cell therapy assets in oncology will generate sales of around $25bn by…
Artificial intelligence (AI) should soon be taking a greater role in areas including patient recruitment and in building efficiencies around…
With the US Food and Drug Administration (FDA) shifting its clinical trial regulations in recent years, working closely with regulators…
The UK’s Labour Government has revealed its ’10-Year Health Plan’ for the country’s National Health Service (NHS). Speaking at a…
US President Donald Trump’s One Big Beautiful Bill Act (H.R. 1) has narrowly passed after US Vice President JD Vance…
The life science industry faces rapid innovation, technological advancement, growing complexity, and uncertainty. In this evolving landscape, convergence of AI,…
The UK’s National Health Service (NHS) is receiving a £29bn ($39.1bn) funding boost, reflecting a 3% annual rise on current…
The US department of Health and Human Services (HHS) has culled the 17 Biden-appointed members on the Advisory Committee for…